Nemaura Medical Inc
F:N18A

Watchlist Manager
Nemaura Medical Inc Logo
Nemaura Medical Inc
F:N18A
Watchlist
Price: 0.115 EUR Market Closed
Market Cap: 3.3m EUR

Nemaura Medical Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Nemaura Medical Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Nemaura Medical Inc
F:N18A
Research & Development
-$1.9m
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
1%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.9B
CAGR 3-Years
-14%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Research & Development
-$1.5B
CAGR 3-Years
-7%
CAGR 5-Years
-9%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.9B
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
-8%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.2B
CAGR 3-Years
-15%
CAGR 5-Years
-16%
CAGR 10-Years
-20%
No Stocks Found

Nemaura Medical Inc
Glance View

Market Cap
3.3m EUR
Industry
Health Care

Nemaura Medical, Inc. operates as a holding company. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-11-04. The firm is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The firm's subsidiaries include Region Green Limited.

N18A Intrinsic Value
Not Available

See Also

What is Nemaura Medical Inc's Research & Development?
Research & Development
-1.9m USD

Based on the financial report for Dec 31, 2023, Nemaura Medical Inc's Research & Development amounts to -1.9m USD.

What is Nemaura Medical Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-1%

Over the last year, the Research & Development growth was -22%. The average annual Research & Development growth rates for Nemaura Medical Inc have been -3% over the past three years , -1% over the past five years .

Back to Top